NCT00165295View on ClinicalTrials.gov

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Waldenstrom's Macroglobulinemia
Interventions
DRUG

Sildenafil citrate (Viagra)

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00165295 - Sildenafil Citrate in Waldenstrom's Macroglobulinemia | Biotech Hunter | Biotech Hunter